{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:54:09Z","timestamp":1759334049542,"version":"build-2065373602"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the public welfare technology application research projects from the Science and Technology Bureau of Lishui","award":["No. 2023GYX42","No. 2022GYX50"],"award-info":[{"award-number":["No. 2023GYX42","No. 2022GYX50"]}]},{"name":"the study was provided by the Natural Science Foundation of Zhejiang Province","award":["No. LQ23H160049"],"award-info":[{"award-number":["No. LQ23H160049"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14869-4","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:55:57Z","timestamp":1759229757000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative HBsAg seroclearance affects long-term outcomes for hepatitis B virus-related hepatocellular carcinoma after liver resection: a multicenter analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Si-Yu","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Feng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gui-Lin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mu-Gen","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"15","key":"14869_CR1","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380(15):1450\u201362.","journal-title":"N Engl J Med"},{"issue":"2","key":"14869_CR2","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","volume":"156","author":"L Kulik","year":"2019","unstructured":"Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 2019;156(2):477\u201391.","journal-title":"Gastroenterology"},{"issue":"4","key":"14869_CR3","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1097\/SLA.0000000000001866","volume":"264","author":"VM Zaydfudim","year":"2016","unstructured":"Zaydfudim VM, Vachharajani N, Klintmalm GB, et al. Liver resection and transplantation for patients with hepatocellular carcinoma beyond Milan criteria. Ann Surg. 2016;264(4):650\u20138.","journal-title":"Ann Surg"},{"issue":"3","key":"14869_CR4","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"10130","key":"14869_CR5","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/S0140-6736(18)30499-9","volume":"391","author":"S Chen","year":"2018","unstructured":"Chen S, Li J, Wang D, Fung H, Wong LY, Zhao L. The hepatitis B epidemic in China should receive more attention. Lancet. 2018;391(10130):1572.","journal-title":"Lancet"},{"issue":"Suppl","key":"14869_CR6","doi-asserted-by":"publisher","first-page":"S182","DOI":"10.3350\/cmh.2024.0837","volume":"31","author":"S Zhang","year":"2025","unstructured":"Zhang S, Mak LY, Yuen MF, Seto WK. Mechanisms of hepatocellular carcinoma and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis B. Clin Mol Hepatol. 2025;31(Suppl):S182\u201395.","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"14869_CR7","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jhep.2011.05.020","volume":"56","author":"JH Wang","year":"2012","unstructured":"Wang JH, Wang CC, Hung CH, Chen CL, Lu SN. Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early\/early stage hepatocellular carcinoma. J Hepatol. 2012;56(2):412\u20138.","journal-title":"J Hepatol"},{"issue":"10","key":"14869_CR8","doi-asserted-by":"publisher","first-page":"e1541","DOI":"10.1634\/theoncologist.2019-0944","volume":"25","author":"MD Wang","year":"2020","unstructured":"Wang MD, Li C, Liang L, et al. Early and late recurrence of hepatitis B virus-associated hepatocellular carcinoma. Oncologist. 2020;25(10):e1541\u201351.","journal-title":"Oncologist"},{"issue":"6","key":"14869_CR9","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1002\/hep.20240","volume":"39","author":"MF Yuen","year":"2004","unstructured":"Yuen MF, Wong DK, Sablon E, et al. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects. Hepatology. 2004;39(6):1694\u2013701.","journal-title":"Hepatology"},{"issue":"9959","key":"14869_CR10","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","volume":"384","author":"C Tr\u00e9po","year":"2014","unstructured":"Tr\u00e9po C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014;384(9959):2053\u201363.","journal-title":"Lancet"},{"issue":"5","key":"14869_CR11","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1002\/hep.21612","volume":"45","author":"CM Chu","year":"2007","unstructured":"Chu CM, Liaw YF. HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up. Hepatology. 2007;45(5):1187\u201392.","journal-title":"Hepatology"},{"key":"14869_CR12","unstructured":"European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370\u201398."},{"issue":"2","key":"14869_CR13","doi-asserted-by":"publisher","first-page":"e100021","DOI":"10.1136\/egastro-2023-100021","volume":"1","author":"AAR Suarez","year":"2023","unstructured":"Suarez AAR, Zoulim F. Opportunities and challenges for hepatitis B cure. eGastroenterology. 2023;1(2):e100021.","journal-title":"eGastroenterology"},{"issue":"5","key":"14869_CR14","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s12072-016-9709-6","volume":"10","author":"TH Lim","year":"2016","unstructured":"Lim TH, Gane E, Moyes C, Borman B, Cunningham C. HBsAg loss in a New Zealand community study with 28-year follow-up: rates, predictors and long-term outcomes. Hepatol Int. 2016;10(5):829\u201337.","journal-title":"Hepatol Int"},{"issue":"1","key":"14869_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","volume":"57","author":"European Association For The Study Of The Liver","year":"2012","unstructured":"European Association For The Study Of The Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol. 2012;57(1):167\u201385.","journal-title":"J Hepatol"},{"issue":"4","key":"14869_CR16","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1053\/j.gastro.2008.07.008","volume":"135","author":"MF Yuen","year":"2008","unstructured":"Yuen MF, Wong DK, Fung J, et al. HBsAg seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. Gastroenterology. 2008;135(4):1192\u20139.","journal-title":"Gastroenterology"},{"issue":"4","key":"14869_CR17","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1053\/gast.2002.36026","volume":"123","author":"YC Chen","year":"2002","unstructured":"Chen YC, Sheen IS, Chu CM, Liaw YF. Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection. Gastroenterology. 2002;123(4):1084\u20139.","journal-title":"Gastroenterology"},{"issue":"8","key":"14869_CR18","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1136\/gutjnl-2013-305517","volume":"63","author":"GA Kim","year":"2014","unstructured":"Kim GA, Lim YS, An J, et al. HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability. Gut. 2014;63(8):1325\u201332.","journal-title":"Gut"},{"issue":"2","key":"14869_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/jso.24628","volume":"116","author":"JF Qiu","year":"2017","unstructured":"Qiu JF, Ye JZ, Feng XZ, et al. Pre- and post-operative HBsAg levels may predict recurrence and survival after curative resection in patients with HBV-associated hepatocellular carcinoma. J Surg Oncol. 2017;116(2):140\u20138.","journal-title":"J Surg Oncol"},{"issue":"6","key":"14869_CR20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1001\/jamasurg.2013.4648","volume":"149","author":"G Huang","year":"2014","unstructured":"Huang G, Lau WY, Zhou WP, et al. Prediction of hepatocellular carcinoma recurrence in patients with low Hepatitis B virus DNA levels and high preoperative Hepatitis B surface antigen levels. JAMA Surg. 2014;149(6):519\u201327.","journal-title":"JAMA Surg"},{"issue":"4","key":"14869_CR21","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.jhep.2022.05.014","volume":"77","author":"S Yoo","year":"2022","unstructured":"Yoo S, Kim JY, Lim YS, Han S, Choi J. Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection. J Hepatol. 2022;77(4):939\u201346.","journal-title":"J Hepatol"},{"issue":"1","key":"14869_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.hpb.2018.07.005","volume":"21","author":"J Liu","year":"2019","unstructured":"Liu J, Zhang H, Xia Y, et al. Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis. HPB (Oxford). 2019;21(1):1\u201313.","journal-title":"HPB (Oxford)"},{"key":"14869_CR23","doi-asserted-by":"crossref","unstructured":"Pang YY. The Brisbane 2000 terminology of liver anatomy and resections. HPB 2000; 2:333\u201339. HPB (Oxford). 2002;4(2): 99; author reply 99\u2013100.","DOI":"10.1080\/136518202760378489"},{"issue":"1","key":"14869_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1053\/j.gastro.2019.02.049","volume":"157","author":"F Kanwal","year":"2019","unstructured":"Kanwal F, Singal AG. Surveillance for hepatocellular carcinoma: current best practice and future direction. Gastroenterology. 2019;157(1):54\u201364.","journal-title":"Gastroenterology"},{"issue":"2","key":"14869_CR25","doi-asserted-by":"publisher","first-page":"e100002","DOI":"10.1136\/egastro-2023-100002","volume":"1","author":"B Koh","year":"2023","unstructured":"Koh B, Danpanichkul P, Wang M, Tan DJH, Ng CH. Application of artificial intelligence in the diagnosis of hepatocellular carcinoma. eGastroenterology. 2023;1(2):e100002.","journal-title":"eGastroenterology"},{"issue":"2","key":"14869_CR26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, et al. The clavien-dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187\u201396.","journal-title":"Ann Surg"},{"issue":"3","key":"14869_CR27","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/biostatistics\/kxy069","volume":"21","author":"M Berger","year":"2020","unstructured":"Berger M, Schmid M, Welchowski T, Schmitz-Valckenberg S, Beyersmann J. Subdistribution hazard models for competing risks in discrete time. Biostatistics. 2020;21(3):449\u201366.","journal-title":"Biostatistics"},{"issue":"8","key":"14869_CR28","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","volume":"20","author":"YC Hsu","year":"2023","unstructured":"Hsu YC, Huang DQ, Nguyen MH. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol. 2023;20(8):524\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"14869_CR29","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S2468-1253(23)00197-8","volume":"8","author":"Polaris Observatory Collaborators","year":"2023","unstructured":"Polaris Observatory Collaborators. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. Lancet Gastroenterol Hepatol. 2023;8(10):879\u2013907.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"14869_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41575-018-0055-0","volume":"16","author":"M Wong","year":"2019","unstructured":"Wong M, Huang J, George J, et al. The changing epidemiology of liver diseases in the Asia-Pacific region. Nat Rev Gastroenterol Hepatol. 2019;16(1):57\u201373.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"14869_CR31","doi-asserted-by":"publisher","first-page":"175883592412892","DOI":"10.1177\/17588359241289202","volume":"16","author":"W Xu","year":"2024","unstructured":"Xu W, Gong H, Li B, Yin X. Hepatocellular carcinoma in HBsAg seroclearance: clinical features, recurrence, and prognosis following curative hepatectomy. Ther Adv Med Oncol. 2024;16:17588359241289202.","journal-title":"Ther Adv Med Oncol"},{"issue":"3","key":"14869_CR32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jhep.2018.10.014","volume":"70","author":"TC Yip","year":"2019","unstructured":"Yip TC, Wong GL, Chan HL, et al. HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues. J Hepatol. 2019;70(3):361\u201370.","journal-title":"J Hepatol"},{"issue":"2","key":"14869_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3851\/IMP1497","volume":"15","author":"CM Chu","year":"2010","unstructured":"Chu CM, Liaw YF. Hepatitis B surface antigen seroclearance during chronic HBV infection. Antivir Ther. 2010;15(2):133\u201343.","journal-title":"Antivir Ther"},{"issue":"5","key":"14869_CR34","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1016::AID-CNCR10>3.0.CO;2-V","volume":"88","author":"S Kubo","year":"2000","unstructured":"Kubo S, Hirohashi K, Tanaka H, et al. Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma. Cancer. 2000;88(5):1016\u201324.","journal-title":"Cancer"},{"issue":"10","key":"14869_CR35","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1002\/cncr.10557","volume":"94","author":"K Ohkubo","year":"2002","unstructured":"Ohkubo K, Kato Y, Ichikawa T, et al. Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma. Cancer. 2002;94(10):2663\u20138.","journal-title":"Cancer"},{"issue":"10","key":"14869_CR36","doi-asserted-by":"publisher","first-page":"e2340353","DOI":"10.1001\/jamanetworkopen.2023.40353","volume":"6","author":"P Li","year":"2023","unstructured":"Li P, Wang Y, Yu J, et al. Tenofovir vs entecavir among patients with HBV-related HCC after resection. JAMA Netw Open. 2023;6(10):e2340353.","journal-title":"JAMA Netw Open"},{"issue":"10","key":"14869_CR37","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1097\/JS9.0000000000000554","volume":"109","author":"H Linye","year":"2023","unstructured":"Linye H, Zijing X, Xiaoyun Z, Zhihui L, Tianfu W, Chuan L. Tenofovir versus entecavir on the prognosis of hepatitis B-related hepatocellular carcinoma after surgical resection: a randomised controlled trial. Int J Surg. 2023;109(10):3032\u201341.","journal-title":"Int J Surg"},{"issue":"6","key":"14869_CR38","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S1665-2681(19)30978-0","volume":"13","author":"SC Ferreira","year":"2014","unstructured":"Ferreira SC, Chach\u00e1 SG, Souza FF, et al. Factors associated with spontaneous HBsAg clearance in chronic hepatitis B patients followed at a university hospital. Ann Hepatol. 2014;13(6):762\u201370.","journal-title":"Ann Hepatol"},{"issue":"3","key":"14869_CR39","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s00535-013-0821-2","volume":"49","author":"M Kobayashi","year":"2014","unstructured":"Kobayashi M, Hosaka T, Suzuki F, et al. Seroclearance rate of hepatitis B surface antigen in 2,112 patients with chronic hepatitis in Japan during long-term follow-up. J Gastroenterol. 2014;49(3):538\u201346.","journal-title":"J Gastroenterol"},{"issue":"3","key":"14869_CR40","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1365-2893.2011.01542.x","volume":"19","author":"R Idilman","year":"2012","unstructured":"Idilman R, Cinar K, Seven G, et al. Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients. J Viral Hepat. 2012;19(3):220\u20136.","journal-title":"J Viral Hepat"},{"issue":"8","key":"14869_CR41","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1007\/s00535-012-0688-7","volume":"48","author":"T Hosaka","year":"2013","unstructured":"Hosaka T, Suzuki F, Kobayashi M, et al. Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B: results from a nine-year longitudinal study. J Gastroenterol. 2013;48(8):930\u201341.","journal-title":"J Gastroenterol"},{"issue":"3","key":"14869_CR42","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/hep.26376","volume":"58","author":"WK Seto","year":"2013","unstructured":"Seto WK, Wong DK, Fung J, Huang FY, Lai CL, Yuen MF. Reduction of hepatitis B surface antigen levels and hepatitis B surface antigen seroclearance in chronic hepatitis B patients receiving 10 years of nucleoside analogue therapy. Hepatology. 2013;58(3):923\u201331.","journal-title":"Hepatology"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14869-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14869-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14869-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:55:59Z","timestamp":1759229759000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14869-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14869"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14869-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"29 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Medical Ethics Committee of the Fifth Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial People\u2019s Hospital, Eastern Hepatobiliary Surgery Hospital, and Shaoxing Municipal Hospital (NO.2024347). All procedures were in accordance with the ethical standards of the above four Clinical Research Committees and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. As patient identities were anonymized, the ethics committees of the four centers all waived the requirement of informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1467"}}